Peking University Hepatology Institute;
Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Disease;
Peking University People’s Hospital;
Beijing 100044;
China;
Hepatocellular carcinoma; Neoantigen; Hepatitis B virus; Screening and identification; Immunosuppression; Immunotherapy;